Articles tagged with Schizophrenia
The latest APA journal issues explore treatment and risk factors for schizophrenia, as well as medical mistrust and bias. Research also examines the management of borderline personality disorder, including good psychiatric practice and its effectiveness.
Dr. Consuelo Walss-Bass shares her groundbreaking research on schizophrenia, emphasizing the importance of considering both genetic predisposition and environmental factors. She also discusses her work with induced pluripotent stem cells to develop personalized psychiatry and reduce stigma around mental health.
A study by the University of the Basque Country has detected potential biomarkers in the blood that could help predict the risk of developing schizophrenia due to cannabis use. The researchers found significant differences in fatty acid content between cannabis users, individuals with schizophrenia, and those with dual diagnoses.
Researchers at WVU have discovered a way to fine-tune zinc activity to improve messaging in the brain, with potential applications for treating conditions such as autism, schizophrenia and Alzheimer's disease. The study identified new compounds that can selectively change synaptic connections by modulating zinc levels.
Research reveals that placental DNA methylation influences expression of genes associated with psychiatric disorders, suggesting genetic risk manifests during prenatal stage. The study identifies schizophrenia, bipolar disorder, and major depression disorder as most strongly linked conditions.
The March issues of The American Journal of Psychiatry and Psychiatric Services bring together new developments in treating depression, obsessive-compulsive disorder, and schizophrenia. These journal publications highlight the latest advancements in digital mental health innovations.
A new study reveals that schizophrenia's complexity is reflected in the individual brain structures of patients, with some experiencing perceptual disturbances and others cognitive impairments. The research suggests a precision medicine approach could tailor therapies to each patient's unique neurobiological profile.
Research highlights differences in genetic risk of schizophrenia between men and women, with men showing a specific association with positive schizotypy traits. The study suggests that environmental factors may modulate the expression of genetic risk differently in men and women.
Researchers found that empathic disequilibrium, an imbalance between cognitive and emotional empathy, better explains symptoms in various clinical conditions. Prof. Florina Uzefovsky's work suggests this concept can be a powerful diagnostic and treatment tool for autism, schizophrenia, and other disorders.
Researchers from Aarhus University found a machine-learning algorithm that can predict patients with high risk of developing schizophrenia or bipolar disorder within the next five years. The study analyzed electronic health record data and identified key factors, including words describing symptoms in clinical notes.
Researchers discovered a genetic mutation that increases glycine decarboxylase enzyme, linked to schizophrenia behaviors in mice. The study provides a direct genetic link to psychosis and sheds light on the biochemical pathways involved.
Researchers used machine learning to predict diagnostic transition to schizophrenia and bipolar disorder, with schizophrenia being notably easier to forecast. By analyzing routine clinical data, the study suggests a possible approach for early intervention and personalized treatment plans.
Studies identified 153 cases of psychosis caused by brain lesions, which connected to a common circuit in the hippocampus. The circuit, including the rostromedial prefrontal cortex, is a promising target for transcranial magnetic stimulation therapy, potentially improving symptoms in patients with schizophrenia.
A new study published in Brain Medicine reveals that over 26.7% of schizophrenia patients experience distinct manic symptoms, which can be predicted by the severity of positive symptoms such as hallucinations and delusions.
A new study found that the brain's cerebral cortex acts like a memory machine, encoding new experiences and predicting the near future. Novelty detection is a critical function for humans and animals, allowing them to adapt and improve their predictions of future events.
A new study found that cannabis use disorder is increasingly associated with new schizophrenia cases in Ontario, with the proportion rising from 4% to 10%. The trend has tripled over the past 17 years, with heavy cannabis use linked to worsening symptoms and increased risk of psychosis.
Researchers identified a deficit in contrast perception among people with schizophrenia, which affects identifying shapes, textures, and details. Further studies are needed to confirm this relationship and explore the role of medication and other factors.
A cohort study of Medicaid beneficiaries with schizophrenia reveals rapid diffusion of telemedicine care following the COVID-19 pandemic. Within-agency racial and ethnic differences in telemental health care adoption were observed, underscoring the need for monitoring innovation diffusion across vulnerable populations.
Researchers found significant differences in immune cell populations between healthy individuals and people with schizophrenia, with the CD4/CD8 ratio emerging as a potential biomarker for predicting treatment response. Lower levels of mucosal-associated invariant T cells may signify immune dysregulation in schizophrenia.
A recent study has identified distinct features in two types of brain cells, intratelencephalic (IT) neurons and pyramidal tract (PT) neurons, which may affect their vulnerability to neurodevelopmental conditions. The research highlights the importance of understanding how these brain cells exchange information through their synapses.
Dr. Carrie Bearden's groundbreaking work combines genetic and brain development insights to identify early warning signs of psychosis in adolescents. Her research has exciting implications for personalized medicine and targeted preventive treatments.
Emory University MD candidate Fayzan Rab's research investigates the economic and public health implications of psychedelic therapy implementation. His work emphasizes making these innovative treatments accessible to traditionally underserved communities.
A new study has identified a specific connectivity pattern of brain atrophy in schizophrenia, distinct from brain networks associated with other psychiatric disorders. The findings suggest that this network may be a core characteristic of schizophrenia and could inform treatment plans.
Scientists at St. Jude Children's Research Hospital found a link between the chromosomal disorder 22q11.2 deletion syndrome and schizophrenia, with malformations in the cerebellum causing Tbx1 gene loss leading to improper skull formation.
Research from King's College London finds that frequent cannabis use increases psychosis risk, regardless of genetic load for schizophrenia. The study used polygenic risk scores to investigate the relationship between cannabis use and psychosis.
A UT Health San Antonio study found that brain volume changes correlate with social behavior differences in psychiatric conditions such as autism spectrum disorder and schizophrenia. Tbx1 deficiency was associated with decreased brain volume in the amygdala and surrounding cortical regions, affecting desire for social interaction.
A new study by the University of Waterloo found that nearly 68% of Canadian patients who used antipsychotics had more behavioral issues than before medication. Non-drug therapies like music and social interaction have been shown to help manage behavior without antipsychotics.
Researchers identified iTBS over the left dorsolateral prefrontal cortex as the most effective method for treating adults with schizophrenia, improving negative and cognitive symptoms. The treatment approach was well-accepted and well-tolerated by participants.
Research by Prof. Falkai suggests promising new directions in schizophrenia treatment through brain plasticity and myelin regeneration. His work challenges traditional views of the disorder and opens new therapeutic possibilities, particularly when combining aerobic exercise with a repurposed drug.
Researchers at the University of Rochester Medical Center have discovered a potential biomarker for psychosis diagnosis by analyzing brain connectivity patterns. The 'somato-visual' biomarker shows promise in predicting psychosis onset and stratifying patients into clinically meaningful subgroups.
A new study found that cannabis use worsens reduced brain connectivity in individuals at high risk of psychosis. This deficit is associated with symptoms like social withdrawal and lack of motivation, which are difficult to treat with current medications.
A study by Florida Atlantic University found that virtual reality training increased empathy and sympathy towards individuals with mental health conditions in police officers. The training, which simulated realistic scenarios, allowed officers to practice handling complex civilian interactions with greater emotional connection.
A new study found that fampridine can improve working memory in individuals with reduced cognitive function, particularly those with low baseline working memory levels. The drug increased brain excitability and enabled faster processing of stimuli.
A new study found that individuals with hallucinogen-related emergency department visits are at a high risk of developing schizophrenia. The study analyzed health data for over 9.2 million individuals in Ontario, Canada, and found a 21-fold increased risk of schizophrenia compared to the general population.
Researchers at Tufts University and Vanderbilt University developed a biomarker to detect inflexible thinking in schizophrenia. The study found that people with schizophrenia generate unique neural patterns when making decisions based on conflicting information.
Researchers discovered brain cells that map an animal's position in behavioural coordinates, helping understand how the brain generates complex behaviors. The findings may be useful in understanding psychiatric conditions such as schizophrenia.
Researchers developed a method to visualize AMPA receptors using PET scans, revealing differences in density and distribution between healthy subjects and those with psychiatric disorders. This discovery may lead to new diagnostic and therapeutic approaches for conditions like schizophrenia, bipolar disorder, and autism spectrum disorder.
A study published in JAMA Psychiatry found a significant association between genetic predisposition and sexual trauma with increased risk for schizophrenia, bipolar disorder, and major depression. The research highlights the importance of considering social and environmental factors in human genetics studies.
Research identifies three clinical subtypes of schizophrenia, differing between subjective and objective social cognitive difficulties, providing a guide for targeted interventions. The study aims to improve individualized treatment approaches for patients with schizophrenia.
Researchers at UCLA Health found an association between childhood attention problems and increased psychosis risk, with genetic variants acting as a middleman. The study used data from over 10,000 children to explore the relationship between attention span variability and psychotic-like symptoms.
A team of scientists, led by Anne Bang, is working to establish clearer connections between genes and their effects on brain function and mental health. They will use high-throughput screening technology to study over 100 genes in brain cells.
Researchers found that people with schizophrenia who experience auditory hallucinations have impaired brain processes, including a 'broken' corollary discharge and 'noisy' efference copy. This impairment may contribute to the loss of ability to distinguish reality from fantasy.
The latest APA journal issues explore schizophrenia spectrum disorders, PTSD treatment, and college mental health. Research highlights include new approaches to psychosis treatment and findings on mental health in higher education.
A recent study reveals significant sex differences in genetic vulnerability to psychotic disorders, including schizophrenia, bipolar disorder, and major depression. The findings suggest that genetic factors contribute to the risk of developing these disorders differently between men and women.
New research identifies critical gaps in mental health care for adults with schizophrenia spectrum disorders. Adults with schizophrenia spectrum disorders experience high rates of comorbid conditions, such as major depressive episode and post-traumatic stress disorder. The study found that only 26% received minimally adequate treatment.
A comprehensive review highlights key findings on the complex relationship between genes and environment in schizophrenia risk, including polygenic risk scores and gene-environment interactions. The study emphasizes the importance of large cohorts and emerging tools to capture the full complexity of schizophrenia risk.
A comprehensive review of genetic and population studies challenges conventional wisdom about the relationship between genetic risk and cognitive deficits in schizophrenia. Premorbid cognitive impairment is largely explained by non-familial factors rather than inherited genetic variants.
A new study mapped genes linked to schizophrenia and uncovered a mechanism disrupting synaptic plasticity in affected individuals. The researchers identified three proteins mediating impairments of plasticity, holding promise for new treatments.
Researchers have found a new brain mechanism that detects prediction errors between expected and actual sensory inputs, boosting responses to unexpected information. This discovery could offer insights into the neural circuits underlying autism spectrum disorders (ASDs) and schizophrenia spectrum disorders (SSDs).
Researchers have discovered a link between cognitive impairments and brain network organization in individuals at risk of developing psychotic disorders such as schizophrenia. This finding suggests an opportunity for early diagnosis and intervention, potentially through non-invasive neuromodulation.
A study published in Neuron reveals that neurons are wired to connect seemingly unrelated concepts, enhancing the brain's ability to predict what we see based on past experiences. Visual experience influences the organisation of feedback projections, which store information about the world.
Researchers have identified nearly 300 common and over 20 rare genetic variants as significant risk factors for schizophrenia. The study emphasizes the role of multiple genes rather than single-gene causation, revealing complexity in the mechanisms underlying the disorder.
A new study analyzed clozapine prescription patterns in patients with first-episode psychosis, finding that approximately 20-30% do not respond to conventional treatments. The use of clozapine can significantly reduce psychotic symptoms and improve quality of life for these patients.
Researchers found individuals with schizophrenia struggle to discriminate between reward levels, leading to apathy and motivation deficits. The study suggests potential treatments, including brain stimulation and targeted psychotherapy.
A novel peptide, KS-133, has been developed to target genetic mechanisms associated with schizophrenia. The nanoparticle-based drug delivery system, where KS-133 is encapsulated with a brain-targeting peptide, shows effective distribution in the brains of mice and improves cognitive functions in mice with induced schizophrenia.
A new study has identified two proteins that play a vital role in modulating cell responses in schizophrenia. The researchers found that these proteins can be targeted to develop drugs that address specific symptoms of the disease, potentially leading to more effective and personalized treatments.
Researchers from the University of South Australia have developed a new coating that targets the gut microbiome to improve antipsychotic medication absorption, mitigating unwanted weight gain. The reformulated Lurasidone reduces weight gain by 8-fold and boosts serotonin levels by over 250%.
This study analyzed resting state fMRI data to investigate salience network disruptions in schizophrenia. The analysis revealed weaker dorsal salience network connectivity and increased ventral salience network connectivity in patients.
Two studies published in Science reveal significant advances in understanding the molecular biology of neuropsychiatric disease, including a comprehensive map of regulatory components of the brain. The research provides critical insights into the pathogenesis of mental health disorders and holds promise for therapeutic applications.
A new study has uncovered unprecedented insights into the cellular basis of schizophrenia, linking genetic risk factors to specific neuronal populations. The research found that excitatory neurons were the most affected cell group, with transcriptional changes implicating neurodevelopment and synaptic signaling.